Pfizer claims Metsera breached their merger agreement, adding that a tie-up of the biotech with GLP-1 drug giant Novo Nordisk ...

CMS’ new $50 billion rural health fund seeks to help rural providers sustain care in their communities over the next five ...

Bayer’s Lynkuet, approved for treating moderate-to-severe vasomotor symptoms of menopause, targets two receptors key to ...

With federal PBM reform stalled, states like California are stepping up with laws like SB 41 to boost transparency and lower drug costs.

This roundup is published monthly. It is meant to highlight some of healthcare’s recent hiring news and is not intended to be comprehensive. If you have news about an executive appointment, ...

Providers increasingly accuse payers of delaying and denying reimbursement for claims. Now, UnitedHealth Group's Optum subsidiary is hoping to change the dynamic through what they claim is a real-time ...

The Supreme Court has made a series of decisions that have implications for healthcare. Below is an overview of these decisions. The Chevron deference In a 6-3 ruling last week, the Supreme Court ...

The expiration of ACA tax credits could drive up premiums across marketplace and commercial insurance plans, a Cigna executive warned.

The blockbuster Sanofi and Regeneron Pharmaceuticals drug Dupixent, already commercialized in several skin and lung disorders, has expanded its FDA-approval to chronic obstructive pulmonary disease ...

Syndax Pharmaceuticals has won FDA approval for a drug addressing advanced cases of acute leukemia carrying a particular genetic signature that leads to an aggressive form of the disease. The ...

The use of AI in healthcare has evolved quite a bit over the past few years — with many healthcare organizations transitioning from a state of cautious experimentation to more serious attempts at ...

The Galapagos pipeline spans both oncology and immunology, but in recent years, the company has invested heavily in cancer cell therapy. The firm is now fully embracing the modality, announcing on ...